Study objective: To examine the baseline factors influencing the occurrence
and magnitude of immediate- and late-phase responses in asthmatic patients
after an allergen-induced bronchial provocation test (A-BPT).
Design: Cross-sectional analysis in a homogenous group of 31 mild, Dermatop
hagoides pteronyssinus-allergic patients with asthma.
Setting: Allergy Department, Hospital Virgen del Camino, Pamplona, Spain.
Interventions and measurements: Patients completed an asthma symptom questi
onnaire and underwent skin tests, sputum induction, and methacholine bronch
ial provocation test. The A-BPT was performed on a separate day. Sputum cel
l profile and eosinophil cationic protein (ECP), tryptase, albumin, and int
erleukin-5 levels were quantified in the entire sputum supernatant. Assays
were done for eosinophils in blood, and/or ECP, and total and specific IgE
levels in serum. Exposure to D pteronyssinus major allergens (Der p1 and De
r 2) was measured by an assay based on monoclonal antibodies.
Results: A-BPT findings were positive in all patients, and late-phase respo
nses were detected in 29%. Late responders were exposed to higher levels of
Der p1 (p = 0.028), had greater levels of ECP (p = 0.007) and albumin (p =
0.019) in sputum, and showed a trend toward higher lymphocyte numbers (p =
0.053) in sputum than isolated early responders. The allergen-induced prov
ocative dose that induced a fall in FEV1 values greater than or equal to 20
% from the postdiluent values correlated with bronchial hyperresponsiveness
(r = 0.36). The late-phase response magnitude correlated with Der pi expos
ure (r = 0.49) and showed a trend toward correlation with sputum ECP levels
(r = 0.38).
Conclusion: Factors involved in the development of allergen-induced immedia
te- and late-phase responses are different. Allergen natural exposure might
prime the infiltration of the airway by activated inflammatory cells enhan
cing the appearance and the severity of late-phase responses.